Q32 BIO INC (QTTB) Stock Analyst Ratings

NASDAQ:QTTB • US7469641051

4.56 USD
-0.2 (-4.2%)
At close: Feb 27, 2026
4.67 USD
+0.11 (+2.41%)
After Hours: 2/27/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to QTTB. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 15.3. This target is 235.53% above the current price.
  • QTTB was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about QTTB.
  • In the previous month the buy percentage consensus was at a similar level.
  • QTTB was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
QTTB Historical Analyst RatingsQTTB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 4.5610.1015.3015.3021.00 - 121.49% 235.53% 235.53% 360.53%

Related screens

Find peers 30% below price target
QTTB Current Analyst RatingQTTB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2026-02-25 HC Wainwright & Co. Initiate Buy
2025-03-12 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2025-02-11 BMO Capital Downgrade Outperform -> Market Perform
2025-02-11 Piper Sandler Downgrade Overweight -> Neutral
2024-12-12 Guggenheim Downgrade Buy -> Neutral
2024-12-12 BMO Capital Maintains Outperform -> Outperform
2024-12-11 Leerink Partners Downgrade Outperform -> Market Perform
2024-12-11 Oppenheimer Maintains Outperform -> Outperform
2024-12-11 Wells Fargo Downgrade Overweight -> Equal-Weight
2024-12-11 Raymond James Downgrade Strong Buy -> Outperform
2024-12-11 Piper Sandler Maintains Overweight -> Overweight
2024-12-06 BMO Capital Initiate Outperform
2024-10-24 Raymond James Initiate Strong Buy
2024-09-11 Wells Fargo Initiate Overweight
2024-06-17 Guggenheim Initiate Buy
2024-05-21 Leerink Partners Initiate Outperform
2024-04-11 Oppenheimer Initiate Outperform
2024-04-02 Piper Sandler Initiate Overweight

Q32 BIO INC / QTTB FAQ

What do analysts expect the price target to be for Q32 BIO INC (QTTB)?

8 analysts have analysed QTTB and the average price target is 15.3 USD. This implies a price increase of 235.53% is expected in the next year compared to the current price of 4.56.


What is the consensus rating for QTTB stock?

The consensus rating for Q32 BIO INC (QTTB) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.